Despite battling a wave of suspected COVID-19 infections, North Korea appears to be preparing to test an intercontinental ballistic missile (ICBM) ahead of US President Joe Biden’s first trip to South Korea, South Korean and US officials said.
An ICBM test appeared imminent, Deputy National Security Adviser Kim Tae-hyo told a briefing in Seoul.
“If there is a small or large North Korean provocation during the summit period, we have prepared Plan B,” he said.
That plan would secure the combined US and South Korea military forces’ defense posture and command and control systems, even if it requires changing the summit schedule, Kim said.
A US official, speaking on condition of anonymity, said that the latest intelligence showed North Korea could carry out an ICBM test as soon as Thursday or Friday.
Biden is expected to arrive in South Korea on Friday and hold talks with his South Korean counterparts over several days before visiting Japan.
The White House said last week Biden was considering a trip to the Demilitarized Zone on the border with North Korea, but Kim said that seemed unlikely.
A weapons test could overshadow Biden’s broader focus on China, trade, and other regional issues, and underscore the lack of progress in denuclearization talks despite his administration’s vow to break the stalemate with practical approaches.
It could also complicate international efforts to offer Pyongyang aid as it battles its first confirmed COVID outbreak.
The trip is Biden’s first to the region as president, and will be the first summit with South Korean President Yoon Suk-yeol, who took office on May 10.
Yoon has vowed to take a harder line against North Korean “provocations,” and is expected to seek greater assurances from Biden that the United States will strengthen its “extended deterrence” against the North.
The Yoon administration has asked the United States to station more nuclear-capable “strategic assets” such as long-range bombers, submarines, and aircraft carriers in the region.
The chances of North Korea conducting a nuclear test this weekend appear low, but if the North stages any major provocation, such assets are ready to be mobilized, Kim said.
US officials had warned that the North could test a nuclear weapon around the visit, and the State Department said on Tuesday there is no expectation that the COVID outbreak would change Pyongyang’s determination to eventually resume nuclear testing, paused since 2017.
“Even as (North Korea) continues to refuse the donation of ... apparently much-needed COVID vaccines, they continue to invest untold sums in ballistic missile and nuclear weapons programs that do nothing to alleviate the humanitarian plight of the North Korean people,” State Department spokesman Ned Price told a briefing.
A new report by the US-based Center for International and Strategic Studies (CSIS) said commercial satellite imagery shows work continuing at the nuclear site, whose underground testing tunnels were shuttered in 2018 after leader Kim Jong Un declared a moratorium on nuclear and ICBM tests.
He has since said that the country is no longer bound by that moratorium because of a lack of progress in talks with the United States. The North resumed testing ICBMs in March.
“The timing of this test rests solely within the hands of Kim Jong Un,” the CSIS report on the nuclear site said.
North Korea has also resumed construction at a long-dormant nuclear reactor that would increase its production of plutonium for nuclear weapons by a factor of 10, researchers at the US-based James Martin Center for Nonproliferation Studies (CNS) reported last week, citing satellite imagery.
Analysts say that even if North Korea tests a weapon, South Korea and the United States should offer unconditional COVID aid.
North Korea sent aircraft to China to pick up medical supplies days after it confirmed its first COVID-19 outbreak, media reported on Tuesday, but Pyongyang has yet to respond to offers of aid from South Korea.
Washington says that it supports providing assistance to North Korea, but that there were no current plans to provide vaccines.